<DOC>
	<DOCNO>NCT00843661</DOCNO>
	<brief_summary>- The aim study compare effect coadministration ezetimibe 10 mg/die + fenofibrate 200 mg/die versus pravastatin 40 mg/die monotherapy HIV-infected patient treat protease inhibitor . - Single-centre , open , randomize , control , prospective pilot study . - 60 patient enrolled order reach target 50 patient evaluable end study . The patient randomly assign 6-month treatment ezetimibe+fenofibrate pravastatin.The visit every month .</brief_summary>
	<brief_title>Coadministration Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy Treatment Hyperlipidaemia HIV-infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>patient older 18 year document positive HIV antibody test stable therapy PIs least 12 month LDLcholesterol &gt; 130 mg/dl triglyceride 200 500 mg/dl nonHDL cholesterol &gt; 160 mg/dl unresponsive dietary measure regular physical exercise history dyslipidemia antiretroviral therapy cardiovascular cerebrovascular disease Cushing 's syndrome concurrent therapy lipidlowering agent , oral anticoagulant , estrogens , thiazidic diuretic , betablockers hypothyroidism Type 1 diabetes mellitus renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Treatment Experienced</keyword>
</DOC>